Centessa Pharmaceuticals (CNTA) Shares Outstanding (2021 - 2026)

Centessa Pharmaceuticals (CNTA) has 6 years of Shares Outstanding data on file, last reported at $154.7 million in Q1 2026.

• Quarterly Shares Outstanding rose 15.85% year-over-year to $154.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $154.7 million (up 15.85% YoY) and the FY2025 annual result came in at $149.2 million, up 12.51% from the prior year.
• Shares Outstanding advanced to $154.7 million in Q1 2026 per CNTA's latest filing, from $149.2 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $154.7 million in Q1 2026 and bottomed at $94.0 million in Q1 2022.
• The 5-year median for Shares Outstanding is $100.5 million (2024), against an average of $114.6 million.
• The widest annual swing landed in 2022, when Shares Outstanding jumped 311.64%; it then rose 1.09% in 2023.
• Tracing CNTA's Shares Outstanding over 5 years: stood at $94.8 million in 2022, then grew by 4.15% to $98.8 million in 2023, then soared by 34.28% to $132.6 million in 2024, then gained by 12.51% to $149.2 million in 2025, then advanced by 3.69% to $154.7 million in 2026.
• Per Business Quant, the three latest CNTA Shares Outstanding figures stand at $154.7 million (Q1 2026), $149.2 million (Q4 2025), and $134.4 million (Q3 2025).

Peer Comparison